Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nitro Games Oyj: Half-Year Report January – June 2021

Reporting period January – June 2021•    Revenues (Jan - Jun): 435,4 KEUR (984,7 KEUR on corresponding period 2020).•    EBITDA: -1 547,9 KEUR (-629,8 KEUR).•    EBIT: -1 848,5 KEUR (-858,1 KEUR). •    Net result: -1 856,8 KEUR (-870,1 KEUR).•    Earnings per share (EPS) -0,2 EUR / share (-0,1 EUR/ share).•    Cash and cash equivalents: 4 625,6 KEUR (30 June 2021). April – June 2021•    Revenues (Apr - Jun): 269,5 KEUR (523,0 KEUR on corresponding period 2020).•    EBITDA: -635,9 KEUR (-420,5 KEUR).•    EBIT: -767,7 KEUR (-534,7 KEUR). •    Net result: -770,6 KEUR (-

Episurf Medical hires Patrick Jamnik to head US business

Episurf Medical (NASDAQ: EPIS B) today announces its hiring of Patrick Jamnik as President of Episurf Medical Inc. In this newly created role, Mr Jamnik will be responsible for all US activities as Episurf Medical continues its international expansion. A veteran of both Stryker and Zimmer-Biomet, Mr Jamnik has extensive experience spanning over 16 years building and commercialising businesses across multiple orthopaedic disciplines in both Europe and the US. In a previous role, Mr Jamnik served as Global Marketing Director at Stanmore Implants, a venture-backed United Kingdom-based

SAS presents traffic program for the fall

As demand for both leisure and business travel increases, SAS continues to expand the number of flights. SAS will be flying more than 160 direct routes to 90 destinations during this fall.SAS increases the flights between the Scandinavian capitals and important destinations in its network to further improve connectivity for travelers. SAS will now be serving all its domestic destinations in Norway and Sweden when the Arlanda-Sundsvall route is reopened in September. In addition, the number of flights to important destinations for travelers in Europe will increase. The rising interest in

InDex Pharmaceuticals strengthens the clinical development organization in preparation of the start of the phase III study CONCLUDE with cobitolimod

August 23, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that two new employees have been appointed in the clinical development organisation in preparation of the start of the phase III study CONCLUDE with cobitolimod.Anders Bröijersén is joining InDex as Senior Medical Director Clinical Operations and Johan Levin as Project Manager Clinical Operations. Anders Bröijersén is a medical doctor and PhD with 15 years of experience in Clinical Development, Medical Affairs and Drug Safety at leading pharmaceutical companies such as Boehringer Ingelheim and MSD. Anders joins

Embellence Group Interim Report Q2 2021

Demand continues to increaseSecond quarter 2021 · Net sales amounted to MSEK 160.0 (120.4), up 32.9% · Organic growth of 21.1% · Adjusted EBITA amounted to MSEK 22.9 (16.7), up 37.1% · EBITA amounted to MSEK 21.2 (16.3), up 30.1% · Net profit for the period amounted to MSEK 13.3 (12.5) and earnings per share before dilution for the period were SEK 0.62 (0.58) · Operating cash flow amounted to MSEK 17.8 (29.2) Significant events during the quarter · New CEO of Wall&decò: Christian Tomadini · Launch of Boråstapeter’s digital flagship store, with its own e-

Liia Nõu appointed new CEO of Pandox

Pandox AB’s (publ) board of directors has appointed Liia Nõu as CEO. Liia Nõu has been Pandox’s CFO since 2007 and acting CEO since 21 May 2021.”Following a structured recruitment process and careful consideration, the board of directors is very pleased to appoint Liia Nõu as CEO of Pandox. Liia Nõu is a modern leader with a long experience from the hotel property market and a person, which both the board of directors and the organisation have great confidence in. The board of directors’ assessment is that Liia Nõu is the best person to balance Pandox’s need of both continuity and change”,

NILAR INTERIM REPORT Q2 2021

CONTINUED STRONG MARKET DEMAND - THE QUARTER AFFECTED BY PRODUCTION DISTURBANCIES April – June 2021 in summary · Revenue 7.2 (7.5) MSEK. · Production 3.3 MWh. · Delivered energy storages 220 (136), average size per energy storage 7 (12) kWh. · Gross profit -84.8 (-39.7) MSEK. · EBITDA -100.6 (-48.5) MSEK. · Operating income (EBIT) -118.7 (-63.1) MSEK. · Net loss -134.7 (-86.0) MSEK. · Earnings per share before/after dilution -4.03 SEK. January – June 2021 in summary · Revenue 12.6 (12.1) MSEK. · Production 6.5 MWh. · Delivered energy storages 293 (

Bulten extends existing FSP contract

Bulten is strengthening an existing FSP (Full Service Provider) contract for the supply of fasteners, with a further order from a European automotive manufacturer. The order is worth approximately SEK 68 million per annum. Deliveries are estimated to start in the fourth quarter of 2021, will reach full pace in 2022, and will run for three years.“The award of further products for an already established FSP contract confirms that our industry-leading position as a full-service provider of fasteners in the automotive industry, along with our responsiveness to customers’ requests, creates new

COVID-19 Phase II clinical trial initiated to evaluate ABNCoV2 as a booster vaccine

Hørsholm, Denmark, August 23, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a Phase II clinical trial to evaluate the ABNCoV2 capsid virus-like particle (cVLP) based COVID-19 vaccine has been initiated by Bavarian Nordic. The trial will investigate the potential of ABNCoV2 as a booster vaccine for individuals with previous COVID-19 disease or vaccination. Initial trial results are expected in the second half of 2021.The trial will enroll 150 healthy adults with existing immunity against SARS-CoV-2, acquired through previous

Photocure to Participate in Nordea’s Annual Small & Mid Cap Days 2021 Investor Conference

Press Release – Oslo, Norway August 23, 2021, Photocure ASA (PHO:OSE): The Bladder Cancer Company focused on delivering transformative solutions to improve the lives of bladder cancer patients,  announces that President and Chief Executive Officer, Daniel Schneider and Chief Financial Officer, Erik Dahl are scheduled to present a corporate overview and participate in meetings with investors at the Nordea Annual Small & Mid Cap Days 2021 conference to be held virtually August 24-26, 2021.Presentation Details · Photocure Presentation: Tuesday, August 24[th] at 3:25pm CET (9:25am EST) ·

Veidekke ASA: To build new residential units for Terrester AB in Torslanda, Sweden

Veidekke has been commissioned by Terrester AB to build the Spitfire neighbourhood, comprising two residential buildings with altogether 75 flats and five semidetached homes, in Amhult in Torslanda near Gothenburg. The design-and-build contract is valued at approx. SEK 135 million and the project is scheduled for completion in the spring of 2023.“Veidekke has built several outstanding projects in Gothenburg and is a contractor in whom we have great confidence. We look forward to a rewarding and fulfilling collaboration,” says Maria Nord Loft, CEO of Amhult 2. “We are very proud that

Invitation to telephone conference in connection with Green Landscaping Group quarterly report January-June 2021

Green Landscaping Group publishes its report for the second quarter 2021 on August 27 at 07:00 CEST.CEO Johan Nordström and CFO Carl-Fredrik Meijer will present the report and answer questions during a telephone conference with a web presentation on August 27 at 10:00 CEST. Participants dial in: Telephone: SE: +46850558374 UK: +443333009269 US: +16467224902Webcast: https://tv.streamfabriken.com/green-landscaping-group-q2-2021 The presentation will be held in English.

Selvaag Bolig ASA: Ex dividend

The shares in Selvaag Bolig ASA will trade ex dividend NOK 2.00 as from today. The payment date is 31 August.   Further information from:Kristoffer Gregersen, executive vice president communications and strategy, Selvaag Bolig ASATelephone: +47 95 77 55 93, e-mail: kgr@selvaagbolig.no  Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at any given time, and focuses on the growth areas in and around Greater Oslo, Bergen, Stavanger and

ABAX launhes greener and future-proofed IoT product line

IoT company, ABAX, has launched a future-proofed hardware product range to help businesses with fleet operations become smarter and more eco-friendly.Called ABAX6,  the company says its new hardware series covers all types of assets and tracking needs that will support businesses looking to future proof their fleet monitoring and management.  Other benefits of the new series include: · Rechargeable batteries · Less power consumption · Components based on future-proofed technology · Local development and production of prototypes Built for the

Read original

Agilyx and Kumho Petrochemical Assess a Chemical Recycling Facility to produce raw material for tires out of post-use plastic

TIGARD, Oregon, USA – August 23, 2021 – Agilyx Corporation (AGLX), a wholly owned subsidiary of Agilyx AS (Euronext Growth (Oslo): “AGLX”) and a pioneer in the advanced recycling of post-use plastics and Kumho Petrochemical, a global leader in the manufacture of synthetic rubber, have announced a collaboration to explore the development and construction of a chemical recycling project in South Korea.“We’re very interested in recycling of post-use plastics, while focusing on utilizing post-use polystyrene into the pure styrene,” stated Jong-Hoon Baek, CEO of Kumho Petrochemical. “

Norway Royal Salmon ASA (NRS): Statement from the Board of Directors NRS

The board of directors of Norway Royal Salmon ASA (NRS) notes the announcement by SalMar ASA on 20 August 2021 that it intends to launch a voluntary cash offer for NRS at a price of NOK 270 per share. The board also refers to NTS ASA's announcement on 11 August 2021 of the increase of the offer price in its mandatory offer to NOK 240 per share. The board of directors is pleased to note that following the initiation of the strategic process after the announcement of NTS ASA's mandatory offer at NOK 209 on 16 July 2021, the shareholders have been presented with offers at significantly

Norway Royal Salmon (NRS): Q2 21 - Operational EBIT of MNOK 94

Norway Royal Salmon (NRS) reports an operational EBIT of MNOK 94 for the second quarter of 2021 and EBIT per kg of NOK 11.74. Corresponding figures for the same quarter last year were MNOK 120 and NOK 17.06. - During the second quarter, we have had a successful start-up of the smolt facility in Dåfjord and good progress on the Arctic Offshore Farming development project. Together with the company's activity in Iceland, these two projects are important for the group's ambition for volume growth. The smolt facility will in the long run ensure the supply of smolts and reduce production

BERGENBIO ASA: LEADERSHIP CHANGE

Bergen, Norway, 22 August 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical need, announces the appointment of Martin Olin as new Chief Executive Officer from 8 September 2021. Following twelve years as CEO of BerGenBio, Richard Godfrey has decided to step down as CEO of the Company with immediate effect to pursue other business interests. Rune Skeie, Chief Financial Officer of BerGenBio, will assume the role of interim CEO until 8 September 2021.    Mr Olin brings more than 20 years of

Peptonic Medical AB has entered into a partnership with Fermata Inc. in Japan

Stockholm, 21th of August 2021, Peptonic Medical (publ) (‘Peptonic’ or ‘the Company’) informs that the company has entered into an agreement with fermata Inc. for the Japan market. The agreement concerns VagiVital®️ and Lunette®️.The agreement concerns early registrations and non-exclusive commercial introduction of VagiVital®️ and Lunette®️ into the Japan market. fermata Inc. has confirmed the regulatory clearance to introduce VagiVital®️ in Japan in September. Lunette®️ will be introduced later in the year. With a successful introductory business build up the parties have agreed to enter

Nel ASA: Exercise of employee share options and issue of shares

(Oslo, 20 August 2021) Nel ASA today has resolved, in accordance with the authorization granted by the general meeting on 15 April 2021, to issue 3,301,000 new shares to fulfil the Company's obligations in the groupwide share option program comprising all employees in Nel fulfilling certain criteria, specified in the Company's annual report (note 6), thereby increasing the Company's share capital by NOK 660,200. In total 148 employees in the group exercised 3,301,000 options, where 3,276,000 options were exercised at the strike price of NOK 7.8, and 25,000 options were exercised at the

MUSTI GROUP PLC: Share Repurchase 20.8.2021

Musti Group Stock Exchange Release 20.8.2021 MUSTI GROUP PLC: Share Repurchase 20.8.2021 In the NASDAQ OMX Helsinki Trade date           20.8.2021Bourse trade         BuyShare                  MUSTIAmount             10 000 SharesAverage price/ share    31,997 EURTotal cost            319 970,00 EUR Company now holds a total of 215 000 sharesincluding the shares repurchased on 20.8.2021 On behalf of Musti Group Nordea Bank Finland Plc Janne Sarvikivi

SBB completes acquisition of 15.0 percent of the shares and votes in Arlandastad Group and resolves on a directed issue of Class B common shares

On 27 July 2021, Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB” or the “Company”) announced an acquisition of 8,544,000 shares in Arlandastad Group AB (publ) (“Arlandastad”), corresponding to 15.0 percent of the shares and votes, for a purchase price of SEK 564,375,000.SBB has today, through its subsidiary SBB i Norden AB (publ), completed the acquisition of  8,544,000 shares in Arlandastad, corresponding to 15.0 percent of the shares and votes, for a purchase price of SEK 564,375,000. As part of such completion, the board of SBB, based on the authorization granted by the Annual

Elkem ASA - Buyback of shares

Oslo, 20 August 2021 Please see below information about transactions made under the share buyback programme for Elkem ASA. · Date on which the buyback programme was announced: 20 July 2021 · The duration of the buyback programme: 20 July 2021 to 26 September 2021 · Size of the buyback programme: Up to 10,000,000 shares From 14 August 2021 until 20 August 2021, Elkem ASA has purchased a total of 1,575,000 own shares at the Oslo Stock Exchange at an average price of NOK 33.9928 per share. Aggregated overview of transactions per day: Date Aggregated

Seadrill New Finance Limited (the “Issuer”) - Financial Information Relating to Seabras JV

Hamilton, Bermuda, August 20, 2021 – Seadrill Limited (“Seadrill” or "the Company") (OSE:SDRL, OTCPK:SDRLF) and the Issuer announce the publication of unaudited financial information for the Seabras JV for the six months ended June 30, 2021.  The Issuer also expects to publish a Fleet Status report for the Seabras JV in the near future. About Seadrill Seadrill is a leading offshore drilling contractor utilizing advanced technology to unlock oil and gas resources for clients across harsh and benign locations across the globe. Seadrill’s high quality, technologically advanced fleet

There are no items matching the current filter
There are no more items matching the current filter
Back to top